Extendicare Inc (EXE.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Extendicare Inc (EXE.TO)

30.69

-0.11 (0.34%)

as of Aug 31, 2026, 7:33:18 pm Market Open.

171 watching

Investor Insights

Aug 31, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

Extendicare Inc. (EXE-T) is highlighted for its strategic positioning within the growing home healthcare sector, effectively capitalizing on demographic trends favoring increased demand for senior care services. The company’s management appears proficient in maintaining healthy margins, particularly as funding from the Ontario government continues to rise. While some experts believe the stock is poised for further growth, they caution about current valuations reflecting high expectations. The company's unique structure as a corporation compared to typical REITs permits a different financial model, making it an intriguing consideration. Furthermore, there are mixed sentiments regarding the stock's immediate prospects, with some experts favoring alternative stocks in the same market due to concerns over potential overvaluation.

Consensus

Cautious

Valuation

Fair Value

Similar

CSH.UN

BUY

A major nursing home operator in North America. 80% of the earnings come from the US. Converting to in income trust which could result in a $28/29 price. Have one of the best franchises in the business. Occupancy rates are very good. Margins are high.

SELL

It looks like the company was put up for auction, but nobody is stopping up to buy it. Would look elsewhere are if you're interested in the healthcare sector.

DON'T BUY

They are doing a strategic review which basically means selling the company. If you own the stock, sell half of it keep half and see what happens. Don't buy.

DON'T BUY

Worries about this industry because of government intervention. Nothing wrong with the fundamental model, but we live in a place where seniors have a lot of political sway and worried about government getting into this industry.

BUY

A first rate company. Looking at it 2/3 years, the demographics are right. They have executed their business plan very well. Good long-term hold.

BUY

The demographics for longer-term care are really good.

WEAK BUY

Might still have some upside. Up 440% in last year.

DON'T BUY

Analysts' expectations are for slightly higher highs. Have been selling some of their Florida assets. Fully priced.

TOP PICK

Has been very solid through the weakness in the market over the last few weeks. Revenue is growing by about 20%. Making acquisitions. Demographics are good.

DON'T BUY

The most obvious way to play the retirement home industry in Canada. Maybe a little further upside, but the easy money has been made.

BUY

Has had a phenomenal recovery. Has been overbought for about four months. Ruled out through a 2001 high. There should be no problem unless you see a loss in momentum. If it dropped below $12.75, it will go down to $8.

BUY ON WEAKNESS

Has had a very good year. Wait for a pullback.

BUY

Have good legs under it.

HOLD

Results have come out better than expected. Should still have some legs. Analysts have a target of $17.

BUY

Has gotten through the worst times. Funding is going to be there from the government. Thinks it can go a lot higher.

Showing 196 to 210 of 237 entries

Most Recent Experts

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Kevin Simpson

Capital Wealth Planning

Jim Lebenthal

Cerity Partners

Bill Baruch, Founder, Blue Line Capital

Blue Line Capital

Brianne Gardner

Raymond James

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Extendicare Inc (EXE.TO)